Twin-Dendritic Organogelators
FULL PAPER
1H NMR (CDCl3,TMS): d=7.27 (d,8H),7.20 (d,4H),6.84 (d,8H),6.70
(d,4H),4.92 (s,4H),4.89 (s,8H),3.89 (m,12H),3.50 (q,4H),2.74 (t,
4H),1.84 (m,17H),1.44 (m,12H),1.26 (m,96H),0.83 ppm (t,18H);
13C NMR (CDCl3,TMS): d=167.66,159.44,159.36,153.24,141.90,
130.59,130.31,129.93,129.71,129.02,114.82,114.50,107.76,75.17,71.79,
68.47,68.38,48.20,39.24,32.34,30.10,30.06,30.03,29.89,29.77,29.74,
29.57,26.50,23.10,14.52 ppm; MALDI-TOF MS: m/z: 2123.92 [M+3H+
+K+],2107.79 [ M+3H++Na+],2085.60 [ M+3H+].
used,to afford a colorless powder (92% yield). 1H NMR (CDCl3,TMS):
d=7.78 (overlapped peaks,d,4H),7.55 (t,1H),6.95 (t,1H),6.86 (dd,
4H),3.96 (t,4H),3.47 (m,4H),3.38 (t,2H),3.31 (q,4H),2.67–2.58 (m,
4H),1.96 (m,2H),1.78–1.75 (two overlapped peaks,m,6H),1.43 (m,
4H),1.26 (m,32H),0.87 ppm (t,6H);
13C NMR (CDCl3,TMS): d=
176.75,173.27,168.03,167.50,162.29,162.17,129.26,126.65,126.49,
114.62,68.62,46.22,43.17,37.87,36.19,32.32,30.07,30.04,30.02,29.99,
29.82,29.75,29.59,28.13,27.88,26.42,23.09,14.51 ppm; MS (ESI):
808.43 [M+H+].
m/z:
N,N-Bis(3-ACHTREUNG(3,4-bis(3’,4’-bis(dodecan-1-yloxy)benzyloxy)benzamido)pro-
pyl)amine (3 f): A synthetic procedure analogous to the synthesis of 3a
was used. Upon completion,the reaction mixture was poured into metha-
nol and filtered. The resulting product was recrystallized from acetone
several times. A colorless solid was obtained (92% yield). 1H NMR
(CDCl3,TMS): d=7.50 (s,2H),7.22 (m,2H),6.95 (d,4H),6.87 (over-
lapped peaks,m,6H),6.79 (d,4H),5.01 (s,8H),3.94 (t,8H),3.88 (t,
8H),3.49 (q,4H),2.72 (t,4H),1.76 (m,20H),1.44 (m,16H),1.26 (m,
128H),0.87 ppm (t,24H); 13C NMR (CDCl3,TMS): d=167.42,152.16,
149.75,149.71,149.44,149.42,149.21,129.36,129.95,129.72,128.27,
120.72,120.61,120.49,114.86,114.22,114.14,113.96,113.73,71.91,71.48,
69.79,69.66,69.65,48.30,39.27,32.35,30.11,30.09,29.95,29.81,29.58,
26.55,26.51,23.10,14.50 ppm; MALDI-TOF MS: m/z: 2275.51 [M+K+],
2260.23 [M+Na+],2237.94 [ M+].
N,N-Bis(3-ACHTRE(GNU 3,4-bis(dodecan-1-yloxy)benzamido)propyl)amino-4-oxo-buta-
noic acid (4b): A synthetic procedure analogous to the synthesis of 4d
was used,to afford a colorless powder in 93% yield. 1H NMR (CDCl3,
TMS): d=8.06 (t,1H),7.46 (d,2H),7.38 (m,2H),7.28 (t,1H),6.81
(overlapped peaks,m,2H),3.99 (overlapped peaks,m,8H),3.45 (m,
4H),3.32 (m,2H),3.29 (m,2H),2.60 (m,2H),2.57 (m,2H),1.95 (m,
2H),1.81 (m,8H),1.69 (m,2H),1.43 (m,8H),1.26 (m,64H),0.87 ppm
(t,12H); 13C NMR (CDCl3,TMS): d=173.19,168.03,167.48,152.40,
152.19,149.28,149.17,126.99,126.82,120.39,120.25,113.15,112.82,
112.73,112.55,69.70,69.50,46.22,43.06,37.94,35.99,32.35,30.09. 29.88,
29.80,29.67,29.58,28.15,27.80,26.45,23.12,14.54 ppm; MALDI-TOF
MS: m/z: 1203.43 [M+3H++Na+],1180.13 [ M+3H+].
N,N-Bis(3-(3,4,5-tris[(4’-dodecan-1-yloxy)benzyloxy]benzamido)propyl)-
amino-4-oxo-butanoic acid (4e): A synthetic procedure analogous to the
synthesis of 4d was used and resulted in a white solid as the final product
N,N-Bis(3-ACHTREUNG(3,5-bis(3’,4’-bis(dodecan-1-yloxy)benzyloxy)benzamido)pro-
pyl)amine (3g): A synthetic procedure analogous to the synthesis of 3a
was used. Upon completion,the reaction mixture was poured into metha-
nol and filtered. The resulting product was purified by column chroma-
tography as described for 3c. A colorless solid was obtained (78% yield).
1H NMR (CDCl3,TMS): d=7.48 (s,2H),7.02–6.81 (overlapped peaks,
m,7H),6.66 (s,2H),4.87 (s,8H),3.95 (t,16H),3.46 (q,4H),2.76 (t,
4H),1.81 (m,16H),1.45 (m,16H),1.26 (m,128H),0.87 ppm (t,24H);
13C NMR (CDCl3,TMS): d=167.72,160.42,149.75,149.64,137.16,
129.36,125.92,121.08,114.96,106.48,105.31,70.81,69.77,48.15,39.17,
32.35,30.73,30.13,30.08,29.90,29.89,29.79,29.75,26.51,26.48,23.11,
14.52 ppm; MALDI-TOF MS: m/z: 2277.35 [M+K+],2261.79 [ M+Na+],
2241.56 [M+3H+].
1
(87% yield). H NMR (CDCl3,TMS): d=7.28 (d,8H),7.20 (d,4H),6.82
(d,8H),6.70 (d,4H),4.92 (s,4H),4.89 (s,8H),3.87 (m,12H),3.45 (m,
4H),3.32 (m,84H),2.57 (m,2H),2.53 (m,2H),1.92 (m,2H),1.76 (m,
12H),1.72 (m,2H),1.43 (m,12H),1.26 (m,96H),0.87 ppm (t,18H);
13C NMR (CDCl3,TMS): d=177.58,173.25,167.77,167.18,159.43,
159.36,159.32,153.29,153.24,141.77,141.41,130.55,130.09,129.98,
129.75,129.66,129.51,129.18,129.03,114.82,114.78,114.49,107.48,
106.81,75.17,71.50,71.20,68.48,68.45,68.39,46.44 ppm; MALDI-TOF
MS: m/z: 2224.43 [M+3H++Na+].
N,N-Bis(3-ACHTRE(UGN 3,4-bis(3’,4’-bis(dodecan-1-yloxy)benzyloxy)benzamido)propyl)-
amino-4-oxo-butanoic acid (4 f): A synthetic procedure analogous to the
synthesis of 4d was used,to afford a colorless powder (91% yield).
1H NMR (CDCl3,TMS): d=7.60–7.59 (overlapped peaks,m,3H),7.41
(m,1H),7.00–6.79 (overlapped peaks,m,16H),5.05 (s,4H),5.04 (s,
4H),3.94 (t,8H),3.88 (t,8H),3.48 (m,2H),3.45 (m,2H),3.38 (m,2H),
3.32 (m,2H),2.67 (m,2H),2.63 (m,2H),1.94 (m,2H),1.76 (m,18H),
N,N-Bis(3-ACHTREUNG(3,4-Bis(3’,4’,5’-tris(dodecan-1-yloxy)benzyloxy)benzamido)-
propyl)amine (3h): A synthetic procedure analogous to the synthesis of
3a was used. Upon completion,the reaction mixture was poured into
methanol and filtered. The resulting product was purified by column
chromatography as described for 3c. A colorless solid was obtained
1
(75% yield). H NMR (CDCl3,TMS): d=7.53 (s,2H),7.31 (d,4H),6.88
1.43 (m,16H),1.26 (m,128H),0.88 ppm (t,24H);
13C NMR (CDCl3,
(d,1H),6.59 (d,8H),5.02 (s,8H),3.92–3.86 (overlapped peaks,m,
24H),3.49 (q,4H),2.76 (t,4H),1.74 (m,28H),1.45 (m,24H),1.26 (m,
192H),0.87 ppm (t,36H); 13C NMR (CDCl3,TMS): d=167.68,153.72,
153.66,152.19,138.35,132.27,132.07,128.09,120.80,114.82,114.31,
106.39,106.12,73.82,72.17,71.80,69.54,47.66,38.68,32.35,30.83,30.19,
30.16,30.11,29.94,29.91,29.80,28.99,26.60,23.10,14.49 ppm; MALDI-
TOF MS: m/z: 3008.8 [M+K+],2992.3 [ M+Na+],2971.0 [ M+].
TMS): d=167.70,167.21,152.32,152.11,149.71,149.45,149.40,149.34,
149.25,149.15,129.92,129.62,127.77,127.49,120.75,120.65,120.52,
114.50,114.10,113.91,113.74,71.53,71.42,69.77,69.63,46.12,43.10,
37.98,36.29,32.35,30.11,29.98,29.95,29.84,29.80,29.50,27.87,26.58,
26.53,23.09,14.49 ppm; MALDI-TOF MS:
m/z: 2375.40 [M+K+],
2359.54 [M+Na+]
Typical procedure for the synthesis of ureas: Synthesis of 1,1-bis(3-ACHTREUNG(3,4-
Typical procedure for coupling of amido amines with succinic anhydride:
Synthesis of N,N-bis(3-ACHTREU(NG 3,4-bis[(4’-dodecan-1-yloxy)benzyloxy]benzami-
bis[(4’-dodecan-1-yloxy)benzyloxy]benzamido)propyl)-3-(6-methylhep-
tan-2-yl)urea (5d): CDI (0.13 g,0.79 mmol) was dissolved in anhydrous
THF (25 mL). 2-Amino-6-methylheptane (0.13 mL,0.79 mmol) was
added to that mixture dropwise. The reaction was left to stir for 1 h at
238C. Upon completion of this step (as monitored by TLC),compound
3d (0.79 g,0.53 mmol) was added to the mixture; the mixture was then
refluxed for 6 h. The solvent was evaporated and the resulting solid was
recrystallized twice from acetone to afford a colorless solid (87% yield).
1H NMR (CDCl3,TMS): d=7.58 (s,2H),7.36–7.30 (overlapped peaks,
m,12H),6.90 (d,2H),6.85 (d,8H),5.09 (s,4H),5.08 (s,4H),4.80 (d,
1H),3.94 (t,8H),3.89 (m,1H),3.41 (m,4H),3.34 (m,4H),1.77 (m,
12H),1.43 (m,10H),1.29–1.26 (overlapped peaks,m,67H),1.10 (m,
do)propyl)amino-4-oxo-butanoic acid (4d): Amido amine 3d (1.502 g,
1 mmol) was mixed with succinic anhydride (0.110 g,1.1 mmol). The mix-
ture was dissolved in hot anhydrous THF and refluxed overnight under
argon. The mixture was then poured into water; this resulted in a white
precipitate,which was filtered,washed with water,and recrystallized
from acetone. This procedure provided a colorless solid product (1.329 g,
83% yield). 1H NMR (CDCl3,TMS): d=7.57 (d,2H),7.32 (overlapped
peaks,m,12H),6.80 (overlapped peaks,m,8H),4.99 (m,8H),3.87 (t,
8H),3.38 (m,4H),3.28 (m,4H),2.60 (m,2H),2.53 (m,4H),1.84 (m,
2H),1.65 (m,10H),1.43 (m,8H),1.26 (m,64H),0.87 ppm (t,12H);
13C NMR (CDCl3,TMS): d=177.58,173.25,167.80,167.23,159.37,
152.31,152.07,149.24,149.12,129.66,129.58,129.38,129.23,129.13,
5H),0.87 (t,12H),0.79 ppm (d,6H);
13C NMR (CDCl3,TMS): d=
167.43,159.40,158.60,152.16,149.30,129.61,129.31,129.25,129.02,
127.84,120.66,114.92,114.87,114.50,71.51,71.37,68.48,47.13,44.35,
39.23,38.07,37.12,32.32,30.07,30.01,29.83,29.75,29.72,28.92,28.27,
26.48,24.43,23.09,22.94,22.00,14.50 ppm; MALDI-TOF MS:
1697.10 [M+H++K+],1680.53 [ M+H++Na+],1657.78 [ M+H+].
128.96,128.86,127.67,127.48,120.86,114.86,114.81,114.60,114.0,71.56,
71.28,68.47,46.17,43.00,37.99,36.10,32.33,30.09,30.05,29.86,29.76,
29.73,29.43,28.24,27.78,26.48,23.09,14.52 ppm; MALDI-TOF MS:
m/z:
m/z:
1643.20 [M+3H++K+],1627.27 [ M+3H++Na+],1604.99 [ M+3H+].
N,N-Bis(3-(4-(dodecan-1-yloxy)benzamido)propyl)amino-4-oxo-butanoic
acid (4a): A synthetic procedure analogous to the synthesis of 4d was
1,1-Bis(3-
ACHTRE(UNG 3,4-bis(dodecan-1-yloxy)benzamido)propyl)-3-(6-methylhep-
tan-2-yl)urea (5b): A synthetic procedure analogous to the synthesis of
Chem. Eur. J. 2008, 14,909 – 918
ꢀ 2008 Wiley-VCH Verlag GmbH & Co. KGaA,Weinheim
917